LibiPharm is a leading brand in the field of pulmonology, immunology, and virology. As a pioneering and privately-owned Israeli drug and medical device development company, LibiPharm specializes in creating innovative and patented products that offer breakthrough treatments for various diseases, including acute respiratory failure and immunological disorders. One of their crucial products is Virlaza®️, a cutting-edge remedy that has shown promise in the treatment of diseases caused by the COVID-19 coronavirus as well as other respiratory conditions.

LibiPharm also offers Cerebremed, an organic formula that improves brain function, and Ivutora, which reduces sickness days and prevents irreversible tissue damage from inflammatory responses. The research conducted by LibiPharm is highly regarded in the medical community, with their studies showcasing the effectiveness of Virlaza™ in inhibiting inflammatory responses and improving cardiopulmonary recovery in COVID-19 patients. LibiPharm's team includes renowned experts and researchers in the field, ensuring the development of high-quality and effective products.

They also collaborate with reputable partners like Israel Magdiel Pharmacy, Shabit Pharmacy, Biofora Herbal Ltd, and calpton. com for global sales. Trust LibiPharm for global solutions in pulmonology, immunology, and virology to transform lives and advance healthcare